Literature DB >> 26346180

The power prior: theory and applications.

Joseph G Ibrahim1, Ming-Hui Chen2, Yeongjin Gwon2, Fang Chen3.   

Abstract

The power prior has been widely used in many applications covering a large number of disciplines. The power prior is intended to be an informative prior constructed from historical data. It has been used in clinical trials, genetics, health care, psychology, environmental health, engineering, economics, and business. It has also been applied for a wide variety of models and settings, both in the experimental design and analysis contexts. In this review article, we give an A-to-Z exposition of the power prior and its applications to date. We review its theoretical properties, variations in its formulation, statistical contexts for which it has been used, applications, and its advantages over other informative priors. We review models for which it has been used, including generalized linear models, survival models, and random effects models. Statistical areas where the power prior has been used include model selection, experimental design, hierarchical modeling, and conjugate priors. Frequentist properties of power priors in posterior inference are established, and a simulation study is conducted to further examine the empirical performance of the posterior estimates with power priors. Real data analyses are given illustrating the power prior as well as the use of the power prior in the Bayesian design of clinical trials.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Bayesian design; borrowing; clinical trials; discounting; historical data; informative prior

Mesh:

Year:  2015        PMID: 26346180      PMCID: PMC4626399          DOI: 10.1002/sim.6728

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

1.  Bayesian semiparametric models for survival data with a cure fraction.

Authors:  J G Ibrahim; M H Chen; D Sinha
Journal:  Biometrics       Date:  2001-06       Impact factor: 2.571

2.  Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.

Authors:  Meg A Gamalo; Ram C Tiwari; Lisa M LaVange
Journal:  Pharm Stat       Date:  2013-08-05       Impact factor: 1.894

3.  Heritability estimates from human twin data by incorporating historical prior information.

Authors:  M H Chen; A K Manatunga; C J Williams
Journal:  Biometrics       Date:  1998-12       Impact factor: 2.571

Review 4.  Incorporation of historical data in the analysis of randomized therapeutic trials.

Authors:  Charlotte Rietbergen; Irene Klugkist; Kristel J M Janssen; Karel G M Moons; Herbert J A Hoijtink
Journal:  Contemp Clin Trials       Date:  2011-06-25       Impact factor: 2.226

5.  Bayesian design of noninferiority trials for medical devices using historical data.

Authors:  Ming-Hui Chen; Joseph G Ibrahim; Peter Lam; Alan Yu; Yuanye Zhang
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

6.  Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models.

Authors:  Brian P Hobbs; Daniel J Sargent; Bradley P Carlin
Journal:  Bayesian Anal       Date:  2012-08-28       Impact factor: 3.728

7.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

8.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Authors:  J M Kirkwood; M H Strawderman; M S Ernstoff; T J Smith; E C Borden; R H Blum
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

9.  Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program.

Authors:  Ming-Hui Chen; Joseph G Ibrahim; H Amy Xia; Thomas Liu; Violeta Hennessey
Journal:  Stat Med       Date:  2013-12-16       Impact factor: 2.373

10.  Bayesian methods in clinical trials: a Bayesian analysis of ECOG trials E1684 and E1690.

Authors:  Joseph G Ibrahim; Ming-Hui Chen; Haitao Chu
Journal:  BMC Med Res Methodol       Date:  2012-11-29       Impact factor: 4.615

View more
  36 in total

1.  Improving Hierarchical Models Using Historical Data with Applications in High-Throughput Genomics Data Analysis.

Authors:  Ben Li; Yunxiao Li; Zhaohui S Qin
Journal:  Stat Biosci       Date:  2016-07-08

2.  CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.

Authors:  Mohamed Amine Bayar; Anastasia Ivanova; Gwénaël Le Teuff
Journal:  Comput Methods Programs Biomed       Date:  2019-05-06       Impact factor: 5.428

3.  Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies.

Authors:  Jing Zhang; Chia-Wen Ko; Lei Nie; Yong Chen; Ram Tiwari
Journal:  Stat Methods Med Res       Date:  2018-02-13       Impact factor: 3.021

4.  A New Monte Carlo Method for Estimating Marginal Likelihoods.

Authors:  Yu-Bo Wang; Ming-Hui Chen; Lynn Kuo; Paul O Lewis
Journal:  Bayesian Anal       Date:  2017-02-28       Impact factor: 3.728

5.  Integrating genomic signatures for treatment selection with Bayesian predictive failure time models.

Authors:  Junsheng Ma; Brian P Hobbs; Francesco C Stingo
Journal:  Stat Methods Med Res       Date:  2016-11-01       Impact factor: 3.021

6.  A practical Bayesian adaptive design incorporating data from historical controls.

Authors:  Matthew A Psioda; Mat Soukup; Joseph G Ibrahim
Journal:  Stat Med       Date:  2018-07-22       Impact factor: 2.373

7.  Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.

Authors:  Md S Warasi; Joshua M Tebbs; Christopher S McMahan; Christopher R Bilder
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

8.  Bayesian Design of Non-Inferiority Clinical Trials via the Bayes Factor.

Authors:  Wenqing Li; Ming-Hui Chen; Xiaojing Wangy; Dipak K Dey
Journal:  Stat Biosci       Date:  2017-07-06

9.  Bayesian design of a survival trial with a cured fraction using historical data.

Authors:  Matthew A Psioda; Joseph G Ibrahim
Journal:  Stat Med       Date:  2018-06-25       Impact factor: 2.373

10.  Augmenting Both Arms of a Randomized Controlled Trial Using External Data: An Application of the Propensity Score-Integrated Approaches.

Authors:  Heng Li; Wei-Chen Chen; Chenguang Wang; Nelson Lu; Changhong Song; Ram Tiwari; Yunling Xu; Lilly Q Yue
Journal:  Stat Biosci       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.